Gene · 3921
Papers1,692
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,692
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence. | Biomedicines | 2023 | 38137449 | PubTator, text mining | PubMed |
| Nuclear RPSA senses viral nucleic acids to promote the innate inflammatory response. | Nat Commun | 2023 | 38114488 | PubTator, text mining | PubMed |
| Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2023 | 38075560 | PubTator, text mining | PubMed |
| Proton Compared to X-Irradiation Induces Different Protein Profiles in Oral Cancer Cells and Their Derived Extracellular Vesicles. | Int J Mol Sci | 2023 | 38069306 | PubTator, text mining | PubMed |
| The Effects of Deregulated Ribosomal Biogenesis in Cancer. | Biomolecules | 2023 | 38002277 | PubTator, text mining | PubMed |
| Classification, function, and advances in tsRNA in non-neoplastic diseases. | Cell Death Dis | 2023 | 37973899 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomic Technology and Its Application to Study Skeletal Muscle Cell Biology. | Cells | 2023 | 37947638 | PubTator, text mining | PubMed |
| Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics. | Cancer Cell Int | 2023 | 37880676 | PubTator, text mining | PubMed |
| Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome. | Blood Adv | 2023 | 37792884 | PubTator, text mining | PubMed |
| Profiling of microRNA as a tool to introduce rAAV vectors in gene therapy of breast cancer: A preliminary report. | Adv Clin Exp Med | 2023 | 37771218 | PubTator, text mining | PubMed |
| 3' UTR Deletion of FBXO28 in a Patient with Brain Abnormalities and Developmental Delay. | Genes (Basel) | 2023 | 37761828 | PubTator, text mining | PubMed |
| Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods. | BioData Min | 2023 | 37752578 | PubTator, text mining | PubMed |
| Study on the active ingredients and mechanism of Jiaotai Pill in the treatment of primary insomnia based on network pharmacology and GEO statistics: A review. | Medicine (Baltimore) | 2023 | 37747012 | PubTator, text mining | PubMed |
| The anti-cancer effect of epigallocatechin-3-O-gallate against multiple myeloma cells is potentiated by 5,7-dimethoxyflavone. | FEBS Open Bio | 2023 | 37730921 | PubTator, text mining | PubMed |
| Functional Landscape of African Swine Fever Virus-Host and Virus-Virus Protein Interactions. | Viruses | 2023 | 37631977 | PubTator, text mining | PubMed |
Epigallocatechin gallate (EGCG) inhibits lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells via modulating nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) signaling pathway. | Food Sci Nutr | 2023 | 37576060 | PubTator, text mining | PubMed |
| Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis. | Front Genet | 2023 | 37533434 | PubTator, text mining | PubMed |
| The Effects of Green Tea Catechins in Hematological Malignancies. | Pharmaceuticals (Basel) | 2023 | 37513933 | PubTator, text mining | PubMed |
| Two "Edges" in Our Knowledge on the Functions of Ribosomal Proteins: The Revealed Contributions of Their Regions to Translation Mechanisms and the Issues of Their Extracellular Transport by Exosomes. | Int J Mol Sci | 2023 | 37511213 | PubTator, text mining | PubMed |
| α-Glucosidase inhibition by green, white and oolong teas: in vitro activity and computational studies. | J Enzyme Inhib Med Chem | 2023 | 37470394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3921/papers?page=5